EUVIMED · CrossrefJournal
European Journal of Heart Failure
ISSN 1388-9842 · Oxford University Press (OUP)
Latest articles
Early Implementation of Guideline-Directed Medical Therapy and Outcomes in Cardiogenic Shock Supported by Micro-Axial Flow Pumps
When Risk Becomes a Diagnosis: Biomarker-Driven CKM Stage Migration in Chronic Kidney Disease
Bioelectrical impedance analysis and treatment response to dapagliflozin, spironolactone and their combination: a SOGALDI-PEF analysis
Evaluating the role of lower extremity elastic bandage in patients with acute decompensated heart failure
The lymphatic system: the new target for effective decongestion in decompensated heart failure?
Ventricular arrhythmia–heart failure interaction and mortality in ICD recipients after myocardial infarction
Efficacy of empagliflozin in heart failure with preserved ejection fraction according to the presence of echocardiographic features of diastolic dysfunction in the EMPEROR-Preserved trial
Correction to: The effect of vericiguat on sudden cardiac death: insights from the VICTOR trial
Dipeptidyl peptidase 3-positive circulatory shock: from targetable intensive care unit endotype to Horizon Europe precision-therapy trial
Performance of prediction models for incident heart failure and heart failure hospitalization in individuals with type 2 diabetes: a systematic review and meta-analysis
Rethinking tricuspid regurgitation in heart failure—a pathophysiology-based holistic approach for individualized patient management
Sex differences in heart failure treatment: a signal worth pursuing?
Diagnostic accuracy of N-terminal pro-B type natriuretic peptide thresholds in dyspnoeic patients in the emergency department according to patients’ characteristics: a systematic review and meta-analysis
Sex-based differences in chronic heart failure: a systematic review and meta-analysis of randomized controlled trials
Baseline characteristics and utilization of medical therapies in acute hospitalized and chronic heart failure patients enrolled in GRASP-HF: differences between ICARe-HF and Non-ICARe-HF centres
Clinical trajectory and disease progression in patients with cardio–renal–metabolic syndrome: the CaReMap observational study
Longitudinal proteomic organ-specific ageing in heart failure
The effect of vericiguat on sudden cardiac death: insights from the VICTOR trial
Genitourinary tract infections and SGLT2 inhibitors in heart failure: an EMPEROR-Pooled analysis
Very high-dose loop diuretics for worsening heart failure—a randomized pilot trial
Genitourinary tract infections in SGLT2 inhibitors treated heart failure patients
Impact of dapagliflozin, spironolactone, and their combination on markers of kidney function and injury: an analysis from SOGALDI-PEF
The global epidemiology of heart failure: a comprehensive and contemporary review
Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials
Time in blood pressure range and cardiovascular outcomes in HFmrEF/HFpEF: a pooled participant-level analysis of four large-scale trials
Blood pressure control and outcomes in heart failure patients with preserved ejection fraction: an individual participant data meta-analysis of four major trials
Reply to letter to the editor by Zhou: Early SGLT2 inhibition in acute heart failure: when more urine does not necessarily mean better decongestion
Beyond sex differences: exercise training in HFpEF as treatment of a multisystem syndrome
Integrating genetics and phenotyping in clinical management of dilated and non-dilated left ventricular cardiomyopathy
Evaluation and management of heart failure patients with liver disease: European Journal of Heart Failure international expert position paper
EUVIMED